Analysis of drug-protein binding by ultrafast affinity chromatography using immobilized human serum albumin. - Wikidata - wikimedia - TriplyDB

Analysis of drug-protein binding by ultrafast affinity chromatography using immobilized human serum albumin.

Analysis of drug-protein binding by ultrafast affinity chromatography using immobilized human serum albumin.

http://www.wikidata.org/entity/Q33771010

about

Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments Kinetic analysis of drug-protein interactions by affinity chromatography Immobilised histidine tagged β2-adrenoceptor oriented by a diazonium salt reaction and its application in exploring drug-protein interaction using ephedrine and pseudoephedrine as probes Recent developments in protein-ligand affinity mass spectrometry.Determination of rate constants and equilibrium constants for solution-phase drug-protein interactions by ultrafast affinity extraction.Research in bioanalysis and separations at the University of Nebraska - Lincoln.Analysis of free drug fractions by ultrafast affinity extraction: interactions of sulfonylurea drugs with normal or glycated human serum albumin.Binding of caffeic acid to human serum albumin by the retention data and frontal analysis.Characterization of drug interactions with serum proteins by using high-performance affinity chromatography.Development of enhanced capacity affinity microcolumns by using a hybrid of protein cross-linking/modification and immobilization Analysis of free drug fractions in serum by ultrafast affinity extraction and two-dimensional affinity chromatography using α1-acid glycoprotein microcolumns.Analysis of free drug fractions in human serum by ultrafast affinity extraction and two-dimensional affinity chromatography.Rapid screening of drug-protein binding using high-performance affinity chromatography with columns containing immobilized human serum albumin.Analysis of Hormone-Protein Binding in Solution by Ultrafast Affinity Extraction: Interactions of Testosterone with Human Serum Albumin and Sex Hormone Binding Globulin Analysis of free fractions for chiral drugs using ultrafast extraction and multi-dimensional high-performance affinity chromatography CHROMATOGRAPHIC ANALYSIS OF DRUG INTERACTIONS IN THE SERUM PROTEOME.Analysis of biomolecular interactions using affinity microcolumns: a review.Analytical methods for kinetic studies of biological interactions: A review Analysis of Biological Interactions by Affinity Chromatography: Clinical and Pharmaceutical Applications.Chromatographic studies of drug interactions with alpha1-acid glycoprotein by ultrafast affinity extraction and peak profiling.Analysis of stereoselective drug interactions with serum proteins by high-performance affinity chromatography: A historical perspective.High performance affinity chromatography and related separation methods for the analysis of biological and pharmaceutical agents.Target-directed screening of the bioactive compounds specifically binding to β₂-adrenoceptor in Semen brassicae by high-performance affinity chromatography.A Printed Equilibrium Dialysis Device with Integrated Membranes for Improved Binding Affinity Measurements.Optimizing separations in online comprehensive two-dimensional liquid chromatography.Young investigator: Michelle J Yoo.Screening of α-glucosidase inhibitors from green tea extracts using immobilized enzymes affinity capture combined with UHPLC-QTOF MS analysis.Continuous-flow step gradient mass spectrometry based method for the determination of kinetic parameters of immobilized mushroom tyrosinase in equilibrating conditions: comparison with free enzyme.Identifying the antiasthmatic target of doxofylline using immobilized β2 -adrenoceptor based high-performance affinity chromatography and site-directed molecular docking.Evaluation and optimization of the metal-binding properties of a complex ligand for immobilized metal affinity chromatography.Characterization of solution-phase drug-protein interactions by ultrafast affinity extraction.

P2860

Q27014989-A28887CE-05DD-4512-8B67-CD099834E6D4 Q28069746-63F09DE2-2C16-4916-8680-55868C83E29F Q28538034-8D44CDFE-E00C-47CA-99EF-7BD639C15451 Q33740704-9C8FF50B-4007-40DC-A924-40A3CFC7C636 Q33847684-E06D77F0-1F23-4915-AF20-5E7B41B6007A Q33902643-C200F9BF-E802-4F0C-8EE4-F38E1AA5DE69 Q34625180-517DB14E-6840-41C4-9461-077B3DA4A2BE Q35168670-CB2FC881-9F02-42E8-91A1-EA769655FD3F Q35215569-B6D1A2AF-BBF7-4E76-BB4B-234F73AD373E Q35661019-D71731E8-7966-4E56-BE9D-DDA7B2B10153 Q36494517-87A25CB8-86A2-481D-B789-214DF0724E7B Q36619568-058093AA-613A-47FA-855F-72D478A157E1 Q36763401-169538F7-A73A-498C-988A-9ED027B99C0B Q37179462-26B6E952-BB4A-411D-BA3A-6A1BF0A49D90 Q37267433-F7F79E42-2795-4423-9EDD-A23F8BF5FF69 Q37287840-18362B88-11E1-470F-A0C4-92DE5A24B5D2 Q38191351-75834779-A368-4CC3-A1C5-42A8500D634C Q38363066-064C11B2-3D76-443A-A9C9-40158A6B117C Q38732237-6223A6F4-BFB2-45AD-927F-E7796B204211 Q38861933-F287971A-CC75-4A69-8A38-5E0BFFE31D9F Q39091680-6FC31D7E-3929-433A-8A9C-0B9A07ABC4C1 Q47336088-8744C250-8E9F-42FF-A86F-73658FAC5272 Q47412006-1B4F8328-C30F-42CF-AEFA-47C2AA84C206 Q47988852-A5382941-D2DE-4840-82F6-091B732BCFC8 Q48192903-509A01C9-F0DB-4CF4-BE5A-6E03F1534026 Q48446078-B8230441-C852-4885-B7AA-B6C0DC252B3E Q50462801-D6EE35F9-4F3A-4CF4-8310-9ACF4814F82D Q50669589-A9003B0C-1B11-413C-9946-32894E1CD8EE Q51334162-CCA0BD2C-0F1D-49A6-8288-DBEDFF8DF6D0 Q51620063-92F6CD91-D5F0-49A7-8920-C348ED2C2C3D Q52365560-E470682A-59C4-48A9-A891-7A5E1B05CF5E

P2860

Analysis of drug-protein binding by ultrafast affinity chromatography using immobilized human serum albumin.

http://www.wikidata.org/entity/Q33771010

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Analysis of drug-protein bindi ...... mobilized human serum albumin.

@ast

Analysis of drug-protein bindi ...... mobilized human serum albumin.

@en

type

label

Analysis of drug-protein bindi ...... mobilized human serum albumin.

@ast

Analysis of drug-protein bindi ...... mobilized human serum albumin.

@en

prefLabel

Analysis of drug-protein bindi ...... mobilized human serum albumin.

@ast

Analysis of drug-protein bindi ...... mobilized human serum albumin.

@en

P1433

Q33771010-A155DD58-CADE-485E-A9FC-1587B7853608

P1476

Q33771010-82C1981C-D204-468A-96A9-3AE3C15AD00F

P2093

Q33771010-093B5A7E-D4CB-4F0E-BFC6-7C66F0D39605

Q33771010-51F35B47-39AB-4133-B14A-A99878256F65

Q33771010-AF45F3F9-C82A-4D59-B9FF-B63B5D9CEAF8

Q33771010-FBA143D5-3AC5-4F63-AD68-7E10F711F787

P2860

Q33771010-1708DB36-0ED2-4355-B959-010F270B46A5

Q33771010-1A79B62C-0146-4D49-A271-A4054E42C30D

Q33771010-1E1254E9-3584-4BF4-A7FC-24A6CD1A2C72

Q33771010-23604450-8D4F-4EB7-9201-BE359219745A

Q33771010-24F63D42-CC45-468C-9BDB-B8A7A45B2B44

Q33771010-2A46CBE0-6D49-47B8-B2BB-114279958290

Q33771010-2F81EF54-1D00-4251-ADC8-E0A620ACA07C

Q33771010-313C19E6-C4C5-4447-B258-AA81D4E2F1DA

Q33771010-37D20925-50C2-4755-A7A4-BC492889A598

Q33771010-3818136A-C762-497D-B8D5-DE138C5AB36E

P304

Q33771010-82149F31-DD30-421A-8EEC-68F37654A619

P31

Q33771010-72C71E28-3D2B-4AAF-AAC7-A52A27336589

P356

Q33771010-2011E55E-259B-45C1-8E68-433B0E96E578

P407

Q33771010-D74CCC6D-8B61-423D-843D-BCA314281937

P433

Q33771010-8E1EADF9-4D42-4D90-BF9B-61B81D4DC6E4

P478

Q33771010-D30A7CFB-6E04-4B04-8EB8-E18D1BF41F11

P577

Q33771010-7CBFE603-0888-4B57-BC9D-EFF7DA1F7675

P5875

Q33771010-17F9AB67-8E95-43BD-8CD2-1EB86CDCFE1E

P698

Q33771010-1FD0EE71-545F-4AC1-863A-AFF2E754D090

P932

Q33771010-7D0F7325-E7E4-4910-BFF8-3DB2DD8D680B

P356

J.CHROMA.2010.02.026

P1433

Journal of Chromatography A

P1476

Analysis of drug-protein bindi ...... mobilized human serum albumin.

@en

P2093

Chad J Briscoe

http://www.w3.org/2001/XMLSchema#string

David S Hage

http://www.w3.org/2001/XMLSchema#string

Michelle J Yoo

http://www.w3.org/2001/XMLSchema#string

Rangan Mallik

http://www.w3.org/2001/XMLSchema#string

P2860

Study of the interaction of an anticancer drug with human and bovine serum albumin: spectroscopic approach

Retention data from affinity high-performance liquid chromatography in view of chemometrics.

Protein-based chiral stationary phases for high-performance liquid chromatography enantioseparations.

Evaluation of a glucose sensing antibody using weak affinity chromatography.

Approach for reliable evaluation of drug proteins interactions using surface plasmon resonance technology.

High-performance affinity chromatography and immobilized serum albumin as probes for drug- and hormone-protein binding.

Age-related changes in protein binding of drugs: implications for therapy.

SPR for molecular interaction analysis: a review of emerging application areas.

NMR in pharmacokinetic and pharmacodynamic profiling.

P304

2796-2803

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CHROMA.2010.02.026

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

1217

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41943220

http://www.w3.org/2001/XMLSchema#string

P698

20227701

http://www.w3.org/2001/XMLSchema#string

P932

2849903

http://www.w3.org/2001/XMLSchema#string